100 related articles for article (PubMed ID: 22009194)
1. Alcohol use and mismatch negativity in young patients with psychotic disorder.
Chitty KM; Kaur M; Lagopoulos J; Hickie IB; Hermens DF
Neuroreport; 2011 Dec; 22(17):918-22. PubMed ID: 22009194
[TBL] [Abstract][Full Text] [Related]
2. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations.
Hermens DF; Ward PB; Hodge MA; Kaur M; Naismith SL; Hickie IB
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):822-9. PubMed ID: 20302901
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
[TBL] [Abstract][Full Text] [Related]
4. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
[TBL] [Abstract][Full Text] [Related]
5. The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study.
Chitty KM; Lagopoulos J; Kaur M; Hickie IB; Hermens DF
Int J Neuropsychopharmacol; 2015 Jan; 18(6):. PubMed ID: 25603860
[TBL] [Abstract][Full Text] [Related]
6. Prediction of psychosis by mismatch negativity.
Bodatsch M; Ruhrmann S; Wagner M; Müller R; Schultze-Lutter F; Frommann I; Brinkmeyer J; Gaebel W; Maier W; Klosterkötter J; Brockhaus-Dumke A
Biol Psychiatry; 2011 May; 69(10):959-66. PubMed ID: 21167475
[TBL] [Abstract][Full Text] [Related]
7. Mismatch negativity (MMN) deficiency: a break-through biomarker in predicting psychosis onset.
Näätänen R; Shiga T; Asano S; Yabe H
Int J Psychophysiol; 2015 Mar; 95(3):338-44. PubMed ID: 25562834
[TBL] [Abstract][Full Text] [Related]
8. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
[TBL] [Abstract][Full Text] [Related]
9. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis.
Atkinson RJ; Michie PT; Schall U
Biol Psychiatry; 2012 Jan; 71(2):98-104. PubMed ID: 22000060
[TBL] [Abstract][Full Text] [Related]
10. Mismatch negativity for speech sounds in temporal lobe epilepsy.
Hara K; Ohta K; Miyajima M; Hara M; Iino H; Matsuda A; Watanabe S; Matsushima E; Maehara T; Matsuura M
Epilepsy Behav; 2012 Mar; 23(3):335-41. PubMed ID: 22377331
[TBL] [Abstract][Full Text] [Related]
11. Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.
Schmidt A; Bachmann R; Kometer M; Csomor PA; Stephan KE; Seifritz E; Vollenweider FX
Neuropsychopharmacology; 2012 Mar; 37(4):865-75. PubMed ID: 22030715
[TBL] [Abstract][Full Text] [Related]
12. Tone duration mismatch negativity deficits predict impairment of executive function in schizophrenia.
Toyomaki A; Kusumi I; Matsuyama T; Kako Y; Ito K; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):95-9. PubMed ID: 17764800
[TBL] [Abstract][Full Text] [Related]
13. Effects of NMDA receptor antagonist memantine on mismatch negativity.
Korostenskaja M; Nikulin VV; Kicić D; Nikulina AV; Kähkönen S
Brain Res Bull; 2007 May; 72(4-6):275-83. PubMed ID: 17452287
[TBL] [Abstract][Full Text] [Related]
14. Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats.
Tikhonravov D; Neuvonen T; Pertovaara A; Savioja K; Ruusuvirta T; Näätänen R; Carlson S
Brain Res; 2008 Apr; 1203():97-102. PubMed ID: 18325485
[TBL] [Abstract][Full Text] [Related]
15. Mismatch negativity in bipolar disorder: A neurophysiological biomarker of intermediate effect?
Hermens DF; Chitty KM; Kaur M
Schizophr Res; 2018 Jan; 191():132-139. PubMed ID: 28450056
[TBL] [Abstract][Full Text] [Related]
16. Association between mismatch negativity and global functioning is specific to duration deviance in early stages of psychosis.
Koshiyama D; Kirihara K; Tada M; Nagai T; Fujioka M; Koike S; Suga M; Araki T; Kasai K
Schizophr Res; 2018 May; 195():378-384. PubMed ID: 28986006
[TBL] [Abstract][Full Text] [Related]
17. Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis.
Koshiyama D; Kirihara K; Tada M; Nagai T; Koike S; Suga M; Araki T; Kasai K
Schizophr Res; 2017 Dec; 190():32-38. PubMed ID: 28314681
[TBL] [Abstract][Full Text] [Related]
18. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.
Heekeren K; Daumann J; Neukirch A; Stock C; Kawohl W; Norra C; Waberski TD; Gouzoulis-Mayfrank E
Psychopharmacology (Berl); 2008 Jul; 199(1):77-88. PubMed ID: 18488201
[TBL] [Abstract][Full Text] [Related]
19. Risky alcohol use predicts temporal mismatch negativity impairments in young people with bipolar disorder.
Chitty KM; Kaur M; Lagopoulos J; Hickie IB; Hermens DF
Biol Psychol; 2014 May; 99():60-8. PubMed ID: 24594113
[TBL] [Abstract][Full Text] [Related]
20. Nicotine and the hallucinating brain: effects on mismatch negativity (MMN) in schizophrenia.
Fisher DJ; Grant B; Smith DM; Borracci G; Labelle A; Knott VJ
Psychiatry Res; 2012 Apr; 196(2-3):181-7. PubMed ID: 22425471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
